The pulmonary vasculature locates in the thoracic cavity and is a bridge that connects right and left heart. Pulmonary vascular disease is a term that encompasses multiple cardiorespiratory conditions, which causes structural and/or functional alterations of the pulmonary vasculature. Most pulmonary vascular disease used to be considered recondite, highly lethal and challenging to treat. However, the past few decades have witnessed tremendous progress in the pathogenesis, diagnosis and treatment of pulmonary vascular disease. Taking the endovascular technologies for the treatment of pulmonary vascular disease as an example, refined balloon pulmonary angioplasty has shown promising results as a therapeutic option for patients with inoperable chronic thromboembolic pulmonary hypertension. Accumulating evidence shows that ultrasound-assisted catheter-directed thrombolysis has the potential to become the new tool, with good efficacy and safety records, for the treatment of pulmonary thromboembolism. Recently, a kind of pulmonary stent designed specifically for pulmonary artery stenosis was approved for marketing in China. The minimally invasive interventional techniques are still evolving and constantly improving the diagnosis and treatment of pulmonary vascular disease.
Interventional techniques in pulmonary circulation have advanced by leaps and bounds during the past decades. This Research Topic aims to bring researchers from multi-disciplinary backgrounds together to share expertise in utilizing interventional techniques for the management of pulmonary vascular disease.
Topics of interest for submission include, but not limited to:
1) Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
2) Angioplasty or stent placement for pulmonary artery stenosis.
3) Catheter-directed therapies for pulmonary thromboembolism.
4) Embolization of pulmonary arteriovenous malformations.
5) Use of intravascular imaging in the pulmonary vasculature, such as optical coherence tomography.
6) Transcatheter pulmonary artery denervation for pulmonary hypertension.
7) Other topics relevant to using the interventional technologies for the management of pulmonary vascular disease.
We welcome various types of submissions, original articles, state-of-the-art reviews and high-quality meta-analysis are especially welcomed.
The pulmonary vasculature locates in the thoracic cavity and is a bridge that connects right and left heart. Pulmonary vascular disease is a term that encompasses multiple cardiorespiratory conditions, which causes structural and/or functional alterations of the pulmonary vasculature. Most pulmonary vascular disease used to be considered recondite, highly lethal and challenging to treat. However, the past few decades have witnessed tremendous progress in the pathogenesis, diagnosis and treatment of pulmonary vascular disease. Taking the endovascular technologies for the treatment of pulmonary vascular disease as an example, refined balloon pulmonary angioplasty has shown promising results as a therapeutic option for patients with inoperable chronic thromboembolic pulmonary hypertension. Accumulating evidence shows that ultrasound-assisted catheter-directed thrombolysis has the potential to become the new tool, with good efficacy and safety records, for the treatment of pulmonary thromboembolism. Recently, a kind of pulmonary stent designed specifically for pulmonary artery stenosis was approved for marketing in China. The minimally invasive interventional techniques are still evolving and constantly improving the diagnosis and treatment of pulmonary vascular disease.
Interventional techniques in pulmonary circulation have advanced by leaps and bounds during the past decades. This Research Topic aims to bring researchers from multi-disciplinary backgrounds together to share expertise in utilizing interventional techniques for the management of pulmonary vascular disease.
Topics of interest for submission include, but not limited to:
1) Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
2) Angioplasty or stent placement for pulmonary artery stenosis.
3) Catheter-directed therapies for pulmonary thromboembolism.
4) Embolization of pulmonary arteriovenous malformations.
5) Use of intravascular imaging in the pulmonary vasculature, such as optical coherence tomography.
6) Transcatheter pulmonary artery denervation for pulmonary hypertension.
7) Other topics relevant to using the interventional technologies for the management of pulmonary vascular disease.
We welcome various types of submissions, original articles, state-of-the-art reviews and high-quality meta-analysis are especially welcomed.
